Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Background: Guidelines have classified patients with acute coronary syndrome (ACS) and diabetes as a special population, with specific sections presented for the management of these patients considering their extremely high risk. However, in China up-to-date information is lacking regarding the burden of diabetes in patients with ACS and the potential impact of diabetes status on the in-hospital outcomes of these patients. This study aims to provide updated estimation for the burden of diabetes in patients with ACS in China and to evaluate whether diabetes is still associated with excess risks of early mortality and major adverse cardiovascular and cerebrovascular events (MACCE) for ACS patients. Methods: The Improving Care for Cardiovascular Disease in China-ACS Project was a collaborative study of the American Heart Association and the Chinese Society of Cardiology. A total of 63,450 inpatients with a definitive diagnosis of ACS were included. Prevalence of diabetes was evaluated in the overall study population and subgroups. Multivariate logistic regression was performed to examine the association between diabetes and in-hospital outcomes, and a propensity-score-matched analysis was further conducted. Results: Among these ACS patients, 23,880 (37.6%) had diabetes/possible diabetes. Both STEMI and NSTE-ACS patients had a high prevalence of diabetes/possible diabetes (36.8% versus 39.0%). The prevalence of diabetes/possible diabetes was higher in women (45.0% versus 35.2%, p < 0.001). Even in patients younger than 45 years, 26.9% had diabetes/possible diabetes. While receiving comparable treatments for ACS, diabetes/possible diabetes was associated with a twofold higher risk of all-cause death (adjusted odds ratio 2.04 [95% confidence interval 1.78–2.33]) and a 1.5-fold higher risk of MACCE (adjusted odds ratio 1.54 [95% confidence interval 1.39–1.72]). Conclusions: Diabetes was highly prevalent in patients with ACS in China. Considerable excess risks for early mortality and major adverse cardiovascular events were found in these patients. Trial registration NCT02306616. Registered December 3, 2014
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This results in worse clinical outcomes compared with individuals with normal glucose metabolism.[30][31][32][33]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Li, J., Li, X., Wang, Q., Hu, S., Wang, Y., Masoudi, F. A., Spertus, J. A., Krumholz, H. M., & Jiang, L. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60921-1 · Cited by 431
RetractedToprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Self-citationRoffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Authors/Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,829
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
Self-citation2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595
Research works printed but not linked: 3
- Chinese Society of Cardiology, Editorial Board of Chinese Journal of Cardiology. CSC guidelines for the diagnosis and treatment of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Chin J Cardiol. 2017;5:18.
- Hong TP, Mu YM, Ji LN, Guo XH, Zhu DL, Tong NW, Huo Y, Shen YP, Zhao D, Jiao K, et al. Chinese expert consensus on anti-diabetic agents in treating patients with type 2 diabetes and atherosclerotic cardiovascular disease. Chin J Diabetes. 2017;25(6):481–92.
- Chinese Society of Cardiology. The abnormal glucose metabolism and clinical atherosclerotic cardiovascular disease diagnosis and treatment guidelines. Chin J Cardiol. 2015;43(6):488–506.
Cited by
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Wang, L., Cong, H.-L., Zhang, J.-X., Hu, Y.-C., Wei, A., Zhang, Y.-Y., Yang, H., Ren, L.-B., Qi, W., Li, W.-Y., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01054-z · Cited by 435
Zhang, Y., Ding, X., Hua, B., Liu, Q., Gao, H., Chen, H., Zhao, X.-Q., Li, W., & Li, H. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01236-3 · Cited by 128
Aging and Cardiovascular Disease: Current Status and Challenges
Zhou, M., Zhao, G., Zeng, Y., Zhu, J., Cheng, F., & Liang, W. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2304135 · Cited by 108
Self-citationImpact of diabetes mellitus on mortality rates and outcomes in myocardial infarction
Schmitt, V. H., Hobohm, L., Münzel, T. F., Wenzel, P., Gori, T., & Keller, K. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.11.003 · Cited by 63
Metadata
- Authors
- Zhou, M., Liu, J., Hao, Y., Liu, J., Huo, Y., Smith, S. C., Ge, J., Ma, C., Han, Y., Fonarow, G. C., Taubert, K. A., Morgan, L., Yang, N., Xing, Y., Zhao, D., & the CCC-ACS Investigators
- Affiliations
- Capital Medical University (CN)
- Peking University First Hospital (CN)
- University of North Carolina at Chapel Hill (US)
- Fudan University (CN)
- General Hospital of Shenyang Military Region (CN)
- University of California, Los Angeles (US)
- American Heart Association (US)
- Corresponding author
- Zhao, Dong
- ORCID
- Venue
- Cardiovascular Diabetology
- Published
- 2018-11-27
- Volume
- 17
- Issue
- 1
- Pages
- 147-147
- ISSN
- 1475-2840 (ISSN-L)
- PMC
- PMC6258152
- OpenAlex
- W2902455571
- Cited by
- 103
- References
- 47
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 12 · 2023: 15 · 2022: 27 · 2021: 13 · 2020: 9 · 2019: 2
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cardiovascular Diabetology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- American Heart Association
- Chinese Society of Cardiology
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Keywords
- diabetes mellitus, acute coronary syndrome, diabetes prevalence, hospitalization outcomes, major adverse cardiac and cerebrovascular events, all-cause mortality, ST-elevation myocardial infarction, non-ST-elevation acute coronary syndrome, sex differences, China
- MeSH terms
- ST Elevation Myocardial Infarction, Non-ST Elevated Myocardial Infarction, Adult, Aged, Cause of Death, China, Diabetes Mellitus, Female, Hospitalization, Humans, Male, Middle Aged, Prognosis, Registries, Risk Factors, Time Factors, Prevalence, Hospital Mortality, Risk Assessment, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. https://app.cochat.ai/papers/10.1186/s12933-018-0793-x
- The paper
- Zhou, M., Liu, J., Hao, Y., Liu, J., Huo, Y., Smith, S. C., Ge, J., Ma, C., Han, Y., Fonarow, G. C., Taubert, K. A., Morgan, L., Yang, N., Xing, Y., Zhao, D., & the CCC-ACS Investigators. (2018). Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-018-0793-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.